Organic Active Ingredients TRIZ Cases

Carboxylic acid compounds shift poloxamer gelation temperature above 10°C while maintaining flowability at 4°C.

Chemiluminescent agents produce light via chemical reactions to treat proliferative disorders without photosensitizers.

Adamantyl oxadiazole compounds selectively inhibit 11β-HSD1 reductase while sparing isoform 2, resolving specificity issues in metabolic disorder treatments.

Segmented antisense oligomers induce exon skipping in the myostatin gene, resolving insufficient mRNA inhibition for treating amyotrophy.

Administering SHP2 inhibitors blocks RAS/MAPK pathway hyperactivation, reducing inflammation and treating age-associated disorders.

Film-coated tablet formulation uses micronized ambrisentan and lactose monohydrate to enhance solubility and content uniformity.

Modified nucleotides and lipid nanoparticles extend relaxin half-life, resolving rapid degradation and low efficacy in fibrosis treatment.

A drug coated balloon uses an excipient-free microcrystalline coating on an expanded polytetrafluoroethylene surface to maintain adherence.

Modified sulfated cellobiosides reduce tissue damage in sepsis by selectively neutralizing NETs without impairing neutrophil function.

Chelating agents sequester ferric ions from production equipment, preventing ciclopirox degradation and maintaining antifungal efficacy.

Replacing triphenylphosphine with triphosgene eliminates difficult-to-remove by-products, simplifying workup and boosting yield.

Administering human milk oligosaccharides increases Bifidobacterium adolescentis abundance to improve insulin sensitivity in non-infant patients.

Small molecule heterocyclic compounds inhibit PCSK9 to increase LDL receptor uptake, addressing statin limitations.

Intermittent administration of PI-3 kinase inhibitors reduces side effects like hyperglycemia and rash while maintaining treatment efficacy.

Anti-HER2 glycoantibodies utilize homogeneous Fc glycosylation to enhance therapeutic efficacy through targeted molecular engineering.

Segmented acidic and alkaline solutions stabilize icodextrin during storage while suppressing glucose decomposition products to ensure biocompatibility.

A transparent hydrogel membrane copolymerizes hyaluronic acid with a crosslinking agent to form a contact lens.

Synthetic Dbait molecules bind Ku proteins to hijack the NHEJ DNA repair pathway, overcoming radio-resistance in tumor cells.

Modulating the DAF-9/DAF-12 pathway overcomes drug resistance in debilitating infections like onchocerciasis.

Antibody-TLR agonist conjugates use cleavable linkers to release payloads at tumors, reducing off-target immune activation.

CRISPR/Cas9-mediated genome editing eliminates miR-10b to ablate glioma cells and extend survival in orthotopic GBM models.

Thiadiazolyl derivatives inhibit the ATP-dependent helicase domain of DNA polymerase theta to disrupt alternative end-joining repair pathways.

Alkyl glycoside surfactant stabilizes high-concentration insulin, preventing occlusion risks in infusion pumps.

Magnetic triggering releases an integrin inhibitor in the cecum, reducing systemic toxicity while improving local bioavailability.

Segmenting proteomes into 8-mer units detects molecular mimicry causing COVID-19 cardiac injury, enabling targeted autoimmune therapeutics.

Sphingomyelin lipid nanoparticles encapsulate nucleic acids to overcome low cell permeability and degradation susceptibility.

Merges naltrexone and vitamin D into a single composition to address inadequate symptom alleviation in autoimmune disease management.

A colon-release formulation combines L-tryptophan with specific Lactobacillus strains to produce beneficial metabolites in the distal gastrointestinal tract.

Optimizing empagliflozin particle size to 1–5 µm resolves the trade-off between adhesion during manufacturing and poor dissolution profiles.

Isolated extracellular vesicles enhance glycolytic enzyme expression to improve mitochondrial function in lung tissue.

Synthesizing sulfide compounds with sulfur trioxide and base metals improves yield and flexibility for pharmaceutical applications.

A 19-nor pyrazolyl steroid modulates GABAA receptors to reduce brain excitability and treat depression.

A creatine base dianion compound increases solubility through chemical transformation of traditional salt forms.

Formula I compound inhibits mitochondrial complex I to overcome hypoxia-induced resistance in pancreatic and colorectal cancers.

Novel pyrazolyl-amino-pyrimidinyl derivatives act as potent JAK inhibitors with optimized pharmacokinetic profiles.

Substituted beta-hydroxy amide compounds inhibit PRMT5 enzyme activity to treat cancer and hemoglobinopathies.

Dual crosslinked anthracene-modified glycan hydrogel resolves weak mechanical properties by combining ionic and covalent bonds with light-responsive control.

Formula I compounds modulate Toll-like receptors to balance pro- and anti-inflammatory cytokines, resolving undesirable ratios that limit therapeutic efficacy.

Purified inverse thermosensitive polymer transitions to gel at body temperature to provide durable mucosal elevation during endoscopic procedures.

Neridronic acid treats osteoarthritis by reducing pain, improving mobility, and decreasing bone marrow lesions.

A segmented tablet coating delivers immediate-release sitagliptin around an extended-release metformin core.

Poly(lactic) acid-poly(ethylene)glycol block copolymers extend plasma concentration duration while maintaining targeted delivery effectiveness.

Controlled cooling regurgitation and lyophilization produce stable extracts that treat bacterial infections without manual squeezing limitations.

Replacing the renin-based ratio with angiotensin II levels resolves medication interference and improves diagnostic accuracy.

Cangrelor targets the ALS3 adhesin to inhibit biofilm formation, resolving host toxicity issues associated with traditional antifungal growth inhibitors.

Cetylpyridinium chloride coatings on urinary catheters prevent biofilm formation, addressing the bottleneck of short-lived antimicrobial protection.

A pemetrexed liquid composition maintains stability at room temperature through controlled oxygen levels and antioxidant integration.

Chemically modified asymmetric RNA complexes silence tyrosinase mRNA, reducing melanin while avoiding side effects of conventional agents.

An antisense oligonucleotide inhibits miR-206 to increase BDNF levels and promote synaptic regeneration.

Aryl hydrocarbon receptor agonists activate AHR to inhibit TLR4 signaling, preventing necrotizing enterocolitis in premature infants.

Lycium barbarum extract activates the ERRγ pathway to increase oxidative muscle fibers and aerobic metabolism in skeletal tissue.

5-Carboxamide-2-thiobarbituric acid derivatives stabilize the cleavage complex to block cancer cell proliferation while reducing toxicity and drug resistance.

Distinct X-ray diffraction patterns identify stable beta and gamma crystal forms that resolve humidity sensitivity issues in solid dosage formulations.

A leucine-enriched ketogenic composition stimulates protein synthesis and ATP production through mTOR activation and metabolic shifts.

Arginine composition suppresses polyglutamine aggregates while crossing the blood-brain barrier to treat neurodegenerative diseases.

Heterocyclic compounds modulate Janus Kinase 3 activity to treat autoimmune disorders while minimizing off-target effects.

Ammonia scavengers stimulate branched-chain dehydrogenase activity to lower plasma levels of toxic metabolites.

Protease-cleavable linkers activate antibodies in the tumor microenvironment, resolving cytotoxicity trade-offs while enhancing anti-tumor immune responses.

Trimeprazine derivatives target social behaviors and cognition in fragile X syndrome models while reducing sedative side effects.

Combining these agents reduces amyloid beta aggregation and increases CD8+ T cells to slow memory decline.

Phenylimidazopyrazole derivatives inhibit Tie2 receptor kinase activity, resolving insufficient efficacy and side effects from VEGF-targeted cancer therapies.

Quinoline compounds inhibit AXL kinase via localized structural optimization, resolving the trade-off between high anti-tumor efficacy and metabolic stability.

Extracellular vesicles bypass P-glycoprotein resistance to deliver paclitaxel, reducing systemic toxicity.

A magnesium and glutamine composition treats metabolic syndrome by modulating the gut microbiome.

Segmenting the synthesis into modular steps with preliminary protection groups simplifies the complex pathway and enhances production efficiency.

PKEK peptides regulate melanin production to reverse hyperpigmentation without triggering inflammatory redness.

Optimized pH and adhesive chemistry maintain needle attachment during humid storage, preventing detachment.

FcRγ-deficient NK cells enhance antibody-dependent cellular cytotoxicity while reducing fratricide to sustain tumor regression in combination therapies.

Segmented ligands prevent receptor saturation, enhancing internalization and efficacy for resistant non-Hodgkin's lymphoma.

Bromodomain inhibitors reduce PD-L1 expression on antigen-presenting cells, restoring T-cell responsiveness against tumors.

Methylated withanolide analogs inhibit NF-kB activity, resolving the contradiction between therapeutic efficacy and compound toxicity.

Pre-emptive topical EGCG reduces mast cells and angiogenesis while increasing elastin content, improving cosmetic outcomes.

Multipeptide vaccines loaded with dendritic cells target multiple tumor antigens to prevent escape mutant generation and improve progression-free survival.

Defined polyC:poly(G/I) double-stranded RNA resolves toxicity from rapid degradation while maintaining immune activation potency.

Cadherin-11 antagonists inhibit myofibroblast differentiation to treat non-dermal fibrosis.

NUP plant extract composition reduces nuclear factor κB activity to resolve persistent inflammation in inflammatory bowel disease.

Compounds inhibit galactokinase to prevent galactose-1-phosphate accumulation and chronic complications in classic galactosemia.

A solid oral nicotine formulation combines nicotine-ion exchange resin with a water-soluble inorganic divalent cation salt to deliver active substance.

Concentrating reaction mixtures to specific gravity ranges enables selective crystallization of atorvastatin hemi calcium salt.

Specific piperidine compounds target prokineticin receptors to address insufficient therapeutic effectiveness in gastrointestinal disorders.

Optimized molar ratios and endosomolytic peptides resolve cytotoxicity and lysosomal trapping in siRNA transfection.

CpdA analog achieves selective steroid receptor modulation to inhibit androgen-independent prostate cancer growth while minimizing inflammatory side effects.

Poloxamer 188 seals micromembrane tears in dystrophin-deficient muscles, reducing calcium influx and resolving contraction force deficits.

A nutritional composition combines galacto-oligosaccharides with Bifidobacterium lactis to modulate infant gut microbiota.

Acetyl-leucine administration reduces restless leg syndrome severity via intermediary neurological pathways.

Non-natural amino acid linked dolastatin derivatives form stable covalent linkages with specific reagents.

Amorphous abiraterone acetate solid dosage form reduces food effects and bioavailability variability through rapid disintegration.

Antibodies conjugated with cytotoxic moieties deliver precise therapeutic payloads to KAAG1-expressing ovarian cancer cells, reducing systemic side effects.

Selective CARD9 modulators bridge the gap between genetic findings and therapy by inhibiting TRIM62-mediated ubiquitinylation to reduce NF-kB activation.

Mutagen treatment and genetic screening boost rebaudioside C content to improve sweetness aftertaste.

Protruding elongate drug crystals on the balloon surface enhance tissue contact and restenosis prevention.